Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.23.3
Organization and Basis of Presentation (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 17, 2021
Sep. 30, 2023
Dec. 31, 2022
Mar. 20, 2023
Accumulated deficit   $ (51.3)    
Common stock shares, par value   $ 0.0001 $ 0.0001  
Exercise price per share       $ 0.0001
Cash and cash equivalents   $ 6.6    
Net Cash Used In Operation   $ (5.3) $ (8.8)  
Warrants issued 24,106      
Warrant exercise price $ 112.00      
Initial Public Offering [Member]        
Warrants to purchase one share of common stock 160,714      
Common stock shares, par value $ 0.0001      
Sale of stock 160,714      
Exercise price per share $ 112.00      
Combined Offering Price $ 112.00      
Warrants issued 184,820      
Warrant exercise price $ 112.00 $ 112.00    
Gross proceeds from warrants purchase of common stock $ 15.4      
Issuance costs $ 2.6